J Cancer Prev.  2016 Dec;21(4):227-234. 10.15430/JCP.2016.21.4.227.

Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival

• Kumar A
• Purohit S
• Sharma NK

• KMID: 2367559
• DOI: http://doi.org/10.15430/JCP.2016.21.4.227

Abstract

Breast carcinoma is a heterogeneous disease that has exhibited rapid resistance to treatment in the last decade. Depending genotype and phenotype of breast cancer, there are discernible differences in DNA repair protein responses including DNA double strand break repair. It is a fact that different molecular sub-types of breast carcinoma activate these dedicated protein pathways in a distinct manner. The DNA double-strand damage repair machinery is manipulated by breast carcinoma to selectively repair the damage or insults inflicted by the genotoxic effects of chemotherapy or radiation therapy. The two DNA double-strand break repair pathways employed by breast carcinoma are homologous recombination and non-homologous end joining. In recent decades, therapeutic interventions targeting one or more factors involved in repairing DNA double-strand breaks inflicted by chemo/radiation therapy have been widely studied. Herein, this review paper summarizes the recent evidence and ongoing clinical trials citing potential therapeutic combinatorial interventions targeting DNA double-strand break repair pathways in breast carcinoma.

Keyword

Genotoxic drug; DNA repair; Breast carcinoma; Drug therapy; Radiotherapy

MeSH Terms

Breast Neoplasms*
Breast*
DNA Repair
DNA*
Drug Therapy
Genotype
Homologous Recombination
Phenotype
Radiotherapy
DNA